Bayesian nonparametric estimation of ROC surface under verification bias.


Journal

Statistics in medicine
ISSN: 1097-0258
Titre abrégé: Stat Med
Pays: England
ID NLM: 8215016

Informations de publication

Date de publication:
15 08 2019
Historique:
received: 18 09 2018
revised: 19 02 2019
accepted: 06 04 2019
pubmed: 3 5 2019
medline: 21 10 2020
entrez: 4 5 2019
Statut: ppublish

Résumé

The receiver operating characteristic (ROC) surface, as a generalization of the ROC curve, has been widely used to assess the accuracy of a diagnostic test for three categories. A common problem is verification bias, referring to the situation where not all subjects have their true classes verified. In this paper, we consider the problem of estimating the ROC surface under verification bias. We adopt a Bayesian nonparametric approach by directly modeling the underlying distributions of the three categories by Dirichlet process mixture priors. We propose a robust computing algorithm by only imposing a missing at random assumption for the verification process but no assumption on the distributions. The method can also accommodate covariates information in estimating the ROC surface, which can lead to a more comprehensive understanding of the diagnostic accuracy. It can be adapted and hugely simplified in the case where there is no verification bias, and very fast computation is possible through the Bayesian bootstrap process. The proposed method is compared with other commonly used methods by extensive simulations. We find that the proposed method generally outperforms other approaches. Applying the method to two real datasets, the key findings are as follows: (1) human epididymis protein 4 has a slightly better diagnosis ability compared to CA125 in discriminating healthy, early stage, and late stage patients of epithelial ovarian cancer. (2) Serum albumin has a prognostic ability in distinguishing different stages of hepatocellular carcinoma.

Identifiants

pubmed: 31049998
doi: 10.1002/sim.8181
doi:

Substances chimiques

Biomarkers, Tumor 0
CA-125 Antigen 0
MUC16 protein, human 0
Membrane Proteins 0
WAP Four-Disulfide Core Domain Protein 2 0
WFDC2 protein, human 0
Serum Albumin, Human ZIF514RVZR

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3361-3377

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Rui Zhu (R)

Department of Statistics, North Carolina State University, Raleigh, North Carolina.

Subhashis Ghosal (S)

Department of Statistics, North Carolina State University, Raleigh, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH